- November 22, 2026
- Updated 8:26 am
Guidance on GLP-1 Use During Pregnancy and Breastfeeding
- 29 Views
- admin
- November 17, 2026
- Health Public Health
Guidance on GLP-1 Use During Pregnancy and Breastfeeding
Around one in 300 women are exposed to GLP-1 medications during pregnancy, according to the American College of Obstetricians and Gynecologists (ACOG). However, data about the effects of these weight-loss drugs on pregnancy or the fetus remains unclear.
ACOG Recommendations
ACOG released new guidelines in late October. They recommend patients discontinue GLP-1 use one to two months before becoming pregnant. Additionally, breastfeeding mothers using GLP-1s should closely monitor their infant’s neonatal weight gain. ACOG advises against using GLP-1 medications while breastfeeding preterm infants.
Research Findings
Existing research does not indicate a high risk of congenital issues from GLP-1 use before or during pregnancy. However, there is limited safety data for definitive conclusions. Current studies suggest GLP-1s do not enter human milk, but both obesity and malnutrition can impact breast milk composition. Parents using GLP-1s postpartum should discuss care plans with their doctors, according to ACOG.
This is a fast-moving area of research, so for now we need to proceed with caution and reassess as more data becomes available,said Yvette LaCoursiere, a professor of obstetrics, gynecology, and reproductive sciences at the University of California at San Diego.